comprehensive -WSS

comprehensive

author：comprehensive 2025-08-12 09:13:05 - browse：7

Editor’s note: A recording of the event is embedded below.

Several biosimilar versions of Humira, which for years has been the world’s best-selling medicine, entered the U.S. market over the past year. What has that meant for insurance coverage and the way drugmakers are marketing these medicines? Join leading experts to discuss the impact on the industry and patients.

Sponsor introduction

Thomas Newcomer, vice president and head of U.S. market access, Samsung Bioepis (sponsor)

Featured speakers

Chris M. Brown, president, McAteer
Michael Gonzales, independent health care consultant, Michael Gonzales, LLC; former national and regional account director, AbbVie
Fran Gregory, MBA, PharmD, vice president of emerging therapies, Cardinal Health
Ed Silverman, Pharmalot columnist, senior writer, STAT (moderator)

WSS

Congress must reauthorize a committee to support older Americans

Biotech companies concerned about China biosecurity crackdown

Readout Newsletter: The latest at Gilead, Catalent, and the NIH

Biotech companies concerned about China biosecurity crackdown

House looks to weaken Medicare negotiation

CRISPR pioneers react to Casgevy, first gene

hotspot

comprehensive

Sponsor introduction

Featured speakers

Sponsored By

focus

At least 13 dead in Texas as scorching temps continue

RaDonda Vaught to speak at CommonSpirit event on patient safety

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

A Q&A with Aletha Maybank, AMA’s chief health equity officer

Activists slam private health insurers over coverage restrictions

Obesity now affects over 1 billion people worldwide, study finds

Bright Health sells Medicare Advantage business to Molina

A daunting task: navigating dual Medicare, Medicaid eligibility

Hepatitis C has a cure — but many Americans still lack access to it

Ransomware attacks on hospitals: Study outlines patient impact

entertainment

FogPharma raises $145 million in rare Series E round

How to address the problem of discarded donor organs

Readout LOUD Podcast: Legal insider trading, booming biotech stocks

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

Poor hospice wound care hurts patients and families

Readout LOUD Podcast: Legal insider trading, booming biotech stocks

hotspot

hotspot

knowledge

knowledge